long-term follow-up of tafasitamab and lenalidomide in r/r dlbcl
Published 1 year ago • 194 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
1:41
real-world efficacy of tafasitamab lenalidomide in r/r dlbcl & the importance of patient selection
-
2:31
long-term follow up of study of obinutuzumab, polatuzumab vedotin, and lenalidomide in r/r fl
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
9:16
protrombin time (pt) & activated partial tromboplastin time (aptt)|coagulation analyzer|wila djami
-
5:21
what is prothrombin time?
-
9:25
mgus diagnosis: a step-by-step approach
-
1:17
the latest updates on tafasitamab in dlbcl
-
2:23
re-mind2: observational study comparing tafasitamab lenalidomide to available therapies in r/r dlbcl
-
1:09
tafasitamab for r/r dlbcl
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
1:35
long-term outcomes for patients with ptcl: 10-year follow-up analysis
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:13
tafasitamab plus lenalidomide post-cd19 car-t is associated with poor outcomes in lbcl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:35
long-term follow-up from the oiti trial: ponatinib in patients with cml in italy
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:38
phase ii study of epcoritamab in r/r lbcl